From a technical perspective, Stanley Black & Decker (SWK) is looking like an interesting pick, as it just reached a key level of support. SWK recently overtook the 20-day moving average, and this suggests a short-term bullish trend.The 20-day simple moving average is a popular trading tool. It provides a look back at a stock's price over a 20-day period, and is beneficial to short-term traders since it smooths out price fluctuations and provides more trend reversal signals than longer-term moving averages. ...

Stanley Black & Decker (SWK) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +11.30%. A quarter ago, it was expected that this tool company would post earnings of $1.19 per share when it actually produced earnings of $1.43, delivering a surprise of +20.17%.Over the last four quarters, ...

Investors interested in stocks from the Manufacturing - Tools & Related Products sector have probably already heard of Stanley Black & Decker (SWK) and Lincoln Electric Holdings (LECO) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy ...

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point for fast-moving stocks, which can lead to limited upside or potential losses [2] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify suitable candidates [3] Group 2: Stanley Black & Decker (SWK) Analysis - Stanley Black & Decker (SWK) has shown a four-week price change of 8.9%, indicating growing investor interest [4] - Over the past 12 weeks, SWK's stock has gained 23.3%, with a beta of 1.2, suggesting it moves 20% more than the market [5] - SWK has a Momentum Score of B, indicating a favorable time to invest based on momentum [6] - The stock has a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates, which attract more investors [7] - SWK is currently trading at a Price-to-Sales ratio of 0.84, suggesting it is undervalued at 84 cents for each dollar of sales [7] Group 3: Additional Investment Opportunities - Besides SWK, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [9]

Group 1 - Binary Tree Analytics (BTA) focuses on providing transparency and analytics for capital markets instruments and trades, specifically targeting Closed-End Funds (CEFs), Exchange-Traded Funds (ETFs), and Special Situations [1] - The company aims to deliver high annualized returns while maintaining a low volatility profile, leveraging over 20 years of investment experience [1]

Core Insights - Stanley Black & Decker (SWK) is a well-established industrial company with over 180 years of history, recognized for its diverse range of products including tools, outdoor products, and engineered fastener systems [1] Company Overview - The company primarily serves various markets such as construction (both residential and non-residential), automotive, aerospace, and general industrial sectors [1]

Core Insights - The company reported a GAAP net income of $8.8 million for the third quarter of 2025, an increase from $3.5 million in the same period of 2024 [1] - Income before tax expense for the third quarter of 2025 was $10.7 million, compared to $4.4 million for the third quarter of 2024 [1]

Financial Performance - Total revenues for the three months ended September 30, 2025, were $10,882,000, an increase of 4.4% compared to $10,418,000 for the same period in 2024[12] - Net income for the three months ended September 30, 2025, was $8,780,000, representing a 153.5% increase from $3,468,000 in the prior year[12] - Net income for the nine months ended September 30, 2025, was $16,855,000, compared to $7,616,000 for the same period in 2024, representing a 121% increase[17] - Net cash provided by operating activities increased to $16,987,000 for the nine months ended September 30, 2025, from $16,160,000 in 2024, reflecting a growth of 5.1%[17] - The company reported a net loss before taxes of $660,000 for Q3 2025, compared to a loss of $892,000 in Q3 2024[68] - The company reported a net income of $8,780,000 for the three months ended September 30, 2025, compared to a net loss of $3,468,000 for the same period in 2024, representing a significant turnaround[112] Assets and Liabilities - Total assets decreased to $289,362,000 as of September 30, 2025, from $332,235,000 as of December 31, 2024, reflecting a decline of approximately 12.9%[10] - Total stockholders' equity as of September 30, 2025, was $254,206,000, down from $288,690,000 at the end of 2024, indicating a decrease of about 11.9%[10] - Total liabilities decreased to $35,156,000 as of September 30, 2025, from $43,545,000 as of December 31, 2024, a reduction of approximately 19.3%[10] - The carrying value of finance receivables, net, was $245,396,000 as of September 30, 2025, remaining unchanged from its fair value[105] Credit Losses and Impairments - The provision for credit losses for the three months ended September 30, 2025, was a benefit of $931,000, compared to a provision of $1,385,000 in the same period of 2024[12] - The provision for credit losses for the nine months ended September 30, 2025, was a benefit of $1.59 million, compared to a provision of $10.78 million for the same period in 2024[49] - The company incurred a loss on impairment of intangible assets amounting to $209,000 for the three months ended September 30, 2025[12] - The company reported a loss on impairment of intangible assets of $209,000 for the nine months ended September 30, 2025, compared to $5,771,000 in 2024[17] Cash Flow and Dividends - The company reported a cash dividend of $4.00 per share, totaling $49,078,000[14] - Cash dividends paid amounted to $49,078,000 in 2025, while there were no dividends paid in 2024[19] - The company had cash and cash equivalents of $10,206,000 at the end of the period, down from $17,178,000 at the end of the previous year[19] Finance Receivables - The company’s investment in finance receivables increased to $28,500,000 in 2025 from $17,736,000 in 2024, representing a 61% increase[19] - Total gross finance receivables as of September 30, 2025, amounted to $253.136 million, with term loans contributing $241.634 million and royalties $11.502 million[61] - Nonaccrual finance receivables totaled $11.50 million as of September 30, 2025, compared to $14.83 million as of December 31, 2024, a decrease of 22.5%[52] - The company collected $2.5 million on nonaccrual finance receivables for the nine months ended September 30, 2025, compared to $2.6 million for the same period in 2024[52] Employee and Operational Changes - The company had 9 full-time employees as of September 30, 2025, following the sale of substantially all assets of the Pharmaceutical Development segment[22] Debt and Financing - The Company entered into a revolving credit facility with an initial maximum principal amount of $45 million, with the option to increase it by up to $80 million[72] - The Company issued $30.0 million of 9.00% Senior Notes due 2027, with total net proceeds of approximately $30.6 million after deducting costs[78] - The outstanding balance of the 2027 Senior Notes as of September 30, 2025, was $32.969 million, net of debt issuance costs[79] - The Company recognized $0.9 million and $2.7 million of interest expense related to the Notes for the three and nine months ended September 30, 2025, respectively[81] Market and Economic Conditions - The company has a finance receivables portfolio primarily based on floating interest rates, which exposes it to interest rate risk[160] - Inflation may impact partner companies, potentially affecting their ability to repay loans, which could adversely affect the company's investment valuations[162] - The company does not currently engage in interest rate hedging activities, which may expose it to risks from interest rate fluctuations[161] Revenue Recognition - The company’s pharmaceutical development segment generated fee revenue from a collaboration agreement with AptarGroup, Inc., contributing to its revenue recognition[26] - The Company recognized total contract revenue of $2,153,000 for the nine months ended September 30, 2025, compared to $1,711,000 for the same period in 2024, indicating a year-over-year increase of approximately 25.8%[108]

分组1 - Stanley Black & Decker reported quarterly earnings of $1.43 per share, exceeding the Zacks Consensus Estimate of $1.19 per share, and showing an increase from $1.22 per share a year ago, resulting in an earnings surprise of +20.17% [1] - The company posted revenues of $3.76 billion for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.35%, and showing a marginal increase from $3.75 billion year-over-year [2] - Over the last four quarters, Stanley Black & Decker has surpassed consensus EPS estimates four times and topped consensus revenue estimates two times [2] 分组2 - The stock has underperformed the market, losing about 17.4% since the beginning of the year, while the S&P 500 has gained 16.5% [3] - The current consensus EPS estimate for the coming quarter is $1.52 on revenues of $3.8 billion, and for the current fiscal year, it is $4.56 on revenues of $15.26 billion [7] - The Manufacturing - Tools & Related Products industry is currently in the top 39% of Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Core Viewpoint - Stanley Black & Decker (SWK) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending September 2025, with the consensus outlook indicating a potential impact on the stock price based on actual results compared to estimates [1][2]. Earnings Expectations - The consensus estimate for Stanley Black & Decker's quarterly earnings is $1.19 per share, reflecting a year-over-year decrease of 2.5%, while revenues are projected to be $3.77 billion, representing a 0.5% increase from the previous year [3]. - The consensus EPS estimate has been revised 0.18% higher in the last 30 days, indicating a slight positive adjustment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP (Expected Surprise Prediction) model suggests that the Most Accurate Estimate for Stanley Black & Decker is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.95%, which indicates a bearish outlook from analysts [11]. - The stock currently holds a Zacks Rank of 3 (Hold), complicating predictions of an earnings beat [11]. Historical Performance - In the last reported quarter, Stanley Black & Decker exceeded the expected earnings of $0.38 per share by delivering $1.08, resulting in a surprise of +184.21% [12]. - Over the past four quarters, the company has successfully beaten consensus EPS estimates each time [13]. Industry Comparison - Lincoln Electric Holdings (LECO), a competitor in the Zacks Manufacturing - Tools & Related Products industry, is expected to report earnings of $2.39 per share for the same quarter, reflecting a year-over-year increase of 11.7%, with revenues projected at $1.04 billion, up 5.9% [17][18]. - Despite a recent EPS estimate revision of 1.5% higher for Lincoln Electric, it also has a negative Earnings ESP of -1.22%, combined with a Zacks Rank of 2 (Buy), making predictions of an earnings beat uncertain [18][19].